The DOI matches its Crossref record; 1,061 of the 1,061 references it cites were found in a registry or an index.
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
Abstract
The American Society for Apheresis (ASFA)Journal of Clinical Apheresis(JCA) Special Issue Writing Committee is charged with reviewing, updating, and categorizing indications for the evidence‐based use of therapeutic apheresis (TA) in human disease. In the Ninth Edition, the JCA Special Issue Writing Committee has incorporated systematic review and evidence‐based approaches in the grading of evidence and categorization of apheresis indications to make recommendations on the use of apheresis in a wide variety of diseases and conditions. This edition has largely maintained the general layout and concept of a fact sheet introduced in the Fourth Edition (2007). Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease or medical condition. The Ninth Edition of the JCA Special Issue comprises 91 fact sheets and 166 graded and categorized indications. This includes seven new fact sheets, nine new indications on existing fact sheets, and eight changes in the category for existing indications. The Ninth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 1,001–1,061 of 1,061
Devarbhavi, H. C., Reddy, V. V., & Singh, R. (2019) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2019.02.006 · Cited by 13
Gao, Q., Ma, Y., Zhang, J., Chen, X., Liu, F., Tian, S., & Qu, X. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1777267 · Cited by 13
A Pediatric Case of Severe Pandysautonomia Responsive to Plasmapheresis
Clark, M. B., & Davis, T. (2013) · Journal of Child Neurology · doi:10.1177/0883073812474099 · Cited by 12
Ling, Y., Huang, X., Mitri, G., Lovelace, B., Pham, A. T., Knobler, R., Li, X., & Gao, X. Y. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1587144 · Cited by 12
Therapeutic thrombocytapheresis in myeloproliferative neoplasms: A single‐institution experience
Nguyen, T. H., Bach, K. Q., Vu, H. Q., Nguyen, N., Duong, T. D., & Wheeler, J. (2020) · Journal of Clinical Apheresis · doi:10.1002/jca.21847 · Cited by 12
Case Report: Cardiac Toxicity Associated With Immune Checkpoint Inhibitors
Chen, R., Peng, L., Qiu, Z., Wang, Y., Wei, F., Zhou, M., & Zhu, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.727445 · Cited by 12
Leroux, J., Hirschi, S., Essaydi, A., Bohbot, A., Dégot, T., Schuller, A., Olland, A., Kessler, R., & Renaud-Picard, B. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100913 · Cited by 12
Carfilzomib-Induced Thrombotic Microangiopathy: Focus on Pathogenesis
Eigbire‐Molen, O., Hermelin, D., & Blackall, D. P. (2022) · Journal of Medical Cases · doi:10.14740/jmc3932 · Cited by 12
Postural orthostatic tachycardia syndrome (POTS) as presenting symptom of CIDP
Adamec, I., Bilić, E., Lovrić, M., & Habek, M. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2507-z · Cited by 11
Fante, C. D., & Perotti, C. G. (2017) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.12.010 · Cited by 11
Evaluation and Treatment of Acute and Subacute Hearing Loss: A Review of Pharmacotherapy
Fazel, M. T., Jedlowski, P. M., Cravens, R. B., & Erstad, B. L. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2044 · Cited by 11
Reich, K., Hartjen, A., Reich, J. L. K., Schröder, J., Steingrube, N., Bresch, M., Ertas, B., Falk, T. M., Blödorn‐Schlicht, N., Jäckle, S., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.09.020 · Cited by 11
The Spectrum of Ocular Manifestations in Patients with Waldenström’s Macroglobulinemia
Dammacco, R., Lisch, W., Kivelä, T., Terpos, E., Kastritis, E., Sisto, D., Mavilio, A., Ria, R., Alessio, G., Vacca, A., et al. (2021) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2021.1933068 · Cited by 11
Safadi, K., Chowers, I., Banin, E., Rosin, B., Tiosano, L., & Amer, R. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05409-4 · Cited by 11
Weber, L. L., Dunbar, N. M., Meehan, K. R., Szczepiorkowski, Z. M., & Lansigan, F. (2015) · Journal of Clinical Apheresis · doi:10.1002/jca.21382 · Cited by 10
Self-citationAxelsson, C.-G., & Hallbäck, D. (2013) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2013.07.002 · Cited by 10
Rossi, M., Puccini, R., Romagnoli, M. C., et al. (2009) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2009.00705.x · Cited by 10
Aneke, J., Huntley, N., Porter, J. B., & Eleftheriou, P. (2016) · Nigerian Medical Journal · doi:10.4103/0300-1652.184073 · Cited by 10
Seeing is believing: A review of apheresis therapy in the treatment of ophthalmologic disease
Graham, B. C., Pulido, J. S., & Winters, J. L. (2017) · Journal of Clinical Apheresis · doi:10.1002/jca.21607 · Cited by 10
Ocon, A. J., Rosenblum, M. K., Desemone, J., et al. (2019) · BMJ Case Reports · doi:10.1136/bcr-2018-229097 · Cited by 10
Diagnosis and Treatment of Limbic Encephalitis in the Cancer Patient
Kyritsis, A. P., Markoula, S., Alexiou, G. Α., ASIMAKOPOULOS, A. D., Jabbour, P. M., FOTOPOULOS, A. D., & Sioka, C. (2020) · Future Oncology · doi:10.2217/fon-2020-0080 · Cited by 10
Guillevin, L. (2020) · La Presse Médicale · doi:10.1016/j.lpm.2020.104034 · Cited by 10
Treatment Options for COVID-19–Related Guillain-Barré Syndrome: A Systematic Review of Literature
Goudarzi, S., Esmaeeli, S., Valencia, J. D., Lu, M. E., Hales, R. R., Fehnel, C. R., Conley, C. M., Quraishi, S. A., & Nozari, A. (2021) · The Neurologist · doi:10.1097/nrl.0000000000000342 · Cited by 10
Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series
Solignac, J., Bataille, S., Touzot, M., Bruner, F., Bouchouareb, D., Brunet, P., Ridel, C., & Robert, T. (2021) · Journal of Clinical Apheresis · doi:10.1002/jca.21955 · Cited by 10
Onwuemene, O. A., Nnoruka, C. I., Patriquin, C. J., & Connelly‐Smith, L. S. (2022) · Transfusion · doi:10.1111/trf.17114 · Cited by 10
Self-citationPrus, K. M., Weidner, K. R., & Alquist, C. R. (2022) · Journal of Clinical Apheresis · doi:10.1002/jca.22023 · Cited by 10
Self-citationIshiguro, Y., Ohmori, T., Umemura, K., & Iizuka, M. (2020) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13594 · Cited by 9
Ченцов, В. Б., Tokmalaev, A. K., Kozhevnikova, G. М., Baranova, A. M., Vdovina, E. T., & Emerole, K. C. (2020) · Journal of Tropical Medicine · doi:10.1155/2020/1628270 · Cited by 9
Current and Upcoming Treatment Modalities in Myasthenia Gravis
Ramaswamy, S. B., Singh, S., Hooshmand, S., Cho, J., Sweeney, M., & Govindarajan, R. (2021) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0000000000000377 · Cited by 9
Liang, S., Zheng, Q., Li, M.-S., Lv, M.-Y., Chen, W., & Yang, Y. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06155-6 · Cited by 9
Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy
Dumitrașcu, O., McKeon, A. B., Zuniga, L. A., Grill, M. F., & Goodman, B. P. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000376 · Cited by 8
Berent, T., Derfler, K., Berent, R., & Sinzinger, H. F. (2019) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2019.08.025 · Cited by 8
Viswanathan, S., Schee, J. P., Omar, M. A., & Hiew, F. L. (2020) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13595 · Cited by 8
Hayashi, T., Nakane, S., Mukaino, A., Higuchi, O., Yamakawa, M., Matsuo, H., & Kimura, K. (2022) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864221110048 · Cited by 8
Plasma Exchange in Secondary Progressive Multiple Sclerosis: Twenty-Five Year Follow-Up Study
Khatri, B. O., & Tarima, S. S. (2013) · Journal of Multiple Sclerosis · doi:10.4172/2376-0389.1000102 · Cited by 7
Outcomes of plasma exchange for severe dilated cardiomyopathy in children
Koizumi, K., Hoshiai, M., Toda, T., Katsumata, N., Kise, H., Hasebe, Y., 河野洋介, Kaga, S., Suzuki, S., & Sugita, K. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0830-1 · Cited by 7
Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides
Lewis, D. J., & Duvic, M. A. (2017) · Dermatologic Therapy · doi:10.1111/dth.12485 · Cited by 7
Barzman, D. H., Jackson, H., Singh, U., Griffey, M., Sorter, M., & Bernstein, J. A. (2018) · Case Reports in Psychiatry · doi:10.1155/2018/8189067 · Cited by 7
Sharma, R., Woods, G. M., Creary, S. E., O’Brien, S. H., Stanek, J. R., Hor, K. N., Gallagher, C., Dunn, A. L., & Kumar, R. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27588 · Cited by 7
Extracorporeal treatment in children with acute severe poisoning
Sun, X., Chen, X., Lu, J., Tao, Y., Zhang, L., & Dong, L. (2019) · Medicine · doi:10.1097/md.0000000000018086 · Cited by 7
Suga, K., Yamashita, H., Takahashi, Y., Katagiri, D., Hinoshita, F., & Kaneko, H. (2020) · Medicine · doi:10.1097/md.0000000000019301 · Cited by 7
How do I…perform therapeutic phlebotomy?
Peedin, A. R., & Karp, J. K. (2021) · Transfusion · doi:10.1111/trf.16308 · Cited by 7
Hiew, F. L., Thit, W. M., Alexander, M., Thirugnanam, U. N., Siritho, S., Tan, K., Aye, S. M. M., Ohnmar, O., Estiasari, R., Yassin, N., et al. (2021) · Journal of Central Nervous System Disease · doi:10.1177/11795735211057314 · Cited by 7
Evaluation of clinical studies of the efficacy of therapeutic apheresis
Vamvakas, E. C. (2000) · Journal of Clinical Apheresis · doi:10.1002/(sici)1098-1101(2000)15:1/2<28::aid-jca4>3.0.co;2-n · Cited by 6
Rosales, A., Muñoz, M., Madrid, Á., Chocrón, S., Hernández, J. M., & Ariceta, G. (2017) · Journal of Clinical Apheresis · doi:10.1002/jca.21595 · Cited by 6
Variation in Treatment and Outcomes of Children With Acute Disseminated Encephalomyelitis
Press, C. A., Kirschen, M. P., LaRovere, K. L., Risen, S., Guilliams, K. P., Chung, M. G., Griffith, J. L., Erklauer, J., Peariso, K., Ducharme‐Crevier, L., et al. (2020) · Hospital Pediatrics · doi:10.1542/hpeds.2019-0129 · Cited by 6
Kakimoto, K., Matsuura, M., Fukuchi, T., Hongo, H., Kimura, T., Aoyama, N., Okuda, Y., Aomatsu, K., Kamata, N., Yokoyama, Y., et al. (2020) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaa073 · Cited by 6
Boluda, B., Solana‐Altabella, A., Cano, I., Acuña‐Cruz, E., Rodríguez‐Veiga, R., Ballesta‐López, O., Megías‐Vericat, J. E., Martínez‐Cuadrón, D., Gómez‐Seguí, I., Solves, P., et al. (2021) · Journal of Clinical Apheresis · doi:10.1002/jca.21901 · Cited by 6
Wang, L., Shen, Y., Zeng, H., Zhang, Y., Lou, S., Deng, J.-C., & Luo, Y. H. (2021) · Medicine · doi:10.1097/md.0000000000026587 · Cited by 6
Makhani, S. S., Schwartz, J. E., Vasović, L. V., Desimone, R. A., Kaicker, S. M., Bussel, J. B., Crowe, E. P., Bloch, E. M., Tobian, A. A. R., & Goel, R. (2022) · Journal of Clinical Apheresis · doi:10.1002/jca.22000 · Cited by 6
Therapeutic plasma exchange for intractable pruritus secondary to primary sclerosing cholangitis
Gibson, B., Williams, L. A., Marques, M. B., & Pham, H. P. (2015) · Journal of Clinical Apheresis · doi:10.1002/jca.21436 · Cited by 5
Self-citationEller, P., Flick, H., Schilcher, G., Moazedi‐Fürst, F., Eller, K., Talakić, E., Hermann, J., Allanore, Y., & Olschewski, H. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01386-2 · Cited by 5
Spencer, J. I., Crane, M., Pisa, M., Waldman, A. D., & DeLuca, G. C. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120056 · Cited by 5
Dirim, A. B., Demir, E., Güller, N., et al. (2022) · Journal of Clinical Apheresis · doi:10.1002/jca.21985 · Cited by 5
Buban, K. R., Lawrence, C. E., Zhu, X., Tobian, A. A. R., Gehrie, E. A., Vozniak, S. O., Shrestha, R., Lokhandwala, P. M., & Bloch, E. M. (2022) · Journal of Clinical Apheresis · doi:10.1002/jca.22004 · Cited by 5
Cambier, A., Dossier, C., Hogan, J., Baudouin, V., Maisin, A., Couderc, A., Kwon, T., Gleeson, P. J., & Monteiro, R. C. (2022) · Pediatric Nephrology · doi:10.1007/s00467-021-05381-5 · Cited by 4
A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients
Goldberg, A. C., Dunbar, R. L., Hemphill, L., Babirak, S. P., Wilson, G., Wooten, M., Iydroose, M., Dacus, K. C., Minchew, H., Dutton, J., et al. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.08.005 · Cited by 3
Desensitization and management of allograft rejection
Zaffiri, L. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000878 · Cited by 3
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Gehrie, E. A., Coberly, E. A., Treml, A., Tormey, C. A., & Booth, G. S. (2017) · Journal of Clinical Apheresis · doi:10.1002/jca.21567 · Cited by 2
Management of the Sensitized Cardiac Transplantation Recipient
Mazzei, M. M., Keshavamurthy, S., Timofeeva, O. A., & Toyoda, Y. (2021) · OBM Transplantation · doi:10.21926/obm.transplant.2101130 · Cited by 2
Metadata
- Authors
- Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., Witt, V., Zantek, N. D., & Dunbar, N. M.
- Venue
- Journal of Clinical Apheresis
- Publisher
- Wiley
- Published
- 2023-04
- Volume
- 38
- Issue
- 2
- Pages
- 77-278
- ISSN
- 0733-2459 (ISSN-L)
- 1098-1101
- OpenAlex
- W4362602027
- Cited by
- 684
- References
- 1,061
- FWCI
- 67.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.